General Info

NeuroMetrix was established in 1996 as a spin-off from the Harvard University-Massachusetts Institute of Technology division of health sciences and technology. The company develops neurological diagnostic and therapeutic solutions to maximize quality of care and economic outcomes. The company s proprietary technology includes biosensors that communicate bioelectrical signals between physiological tissue, such as peripheral nerves and electronic instruments; bioelectronic instruments that interface with the biosensors and enable diagnostic and therapeutic procedures; biomedical signal processing, automation and analysis algorithms; and informatics and decision-support software that maximize clinical utility. NeuroMetrix s flagship product, the NC-stat, is a nerve conduction-testing platform that has been on the market since 2000. Orthopedic surgeons, neurosurgeons, neurologists, physiatrists, rheumatologists, internal medicine physicians, occupational health physicians, pain medicine physicians and general practitioners use the NC-stat to assist in the diagnosis or exclusion of peripheral nerve disorders. NeuroMetrix s corporate headquarters is in Waltham, Mass.